Skip to main content
SpringerLink
Log in
Book cover

Approaches to Breast Cancer Prevention pp 53–60Cite as

Growth Factor Expression in Breast Tissue

  • Chapter

Part of the book series: Developments in Oncology ((DION,volume 62))

Abstract

Normal breast growth and differentiation are controlled by a complex system involving oestrogens and a group of locally acting growth factors. The latter are small polypeptides produced by all cells which stimulate cell proliferation by binding to specific cell membrane receptors. They are extremely active biologically, and concentrations as low as 10−12 g may have a proliferative effect.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Sporn, M.B., Roberts, A.B. (1985). Autocrine growth factors and cancer. Nature, 313, 745–747.

    Article  PubMed  CAS  Google Scholar 

  2. Goustin, A.S., Leof, E.B., Shipley, G.D., Moses, H.L. (1986). Growth factors and cancer. Cancer Research, 46, 1015–1029.

    PubMed  CAS  Google Scholar 

  3. Green, S., Chambon, P. (1986). A superfamily of potentially oncogenic hormone receptors. Nature, 324, 615–617.

    Article  PubMed  CAS  Google Scholar 

  4. Schechter, A.L., Hung, M-C., Vaidyanathan, L. et al. (1985). The neu gene: an erb-B-homologous gene distinct from and unlinked to the gene encoding the EGF receptor. Science, 229, 976–978.

    Article  PubMed  CAS  Google Scholar 

  5. Levine, E.G., King, R.A., Bloomfield, C.D. (1989). The role of heredity in cancer. J. Clin. Oncol., 7(4), 527–540.

    PubMed  CAS  Google Scholar 

  6. DeLarco, J.E., Todaro, G.J. (1978). Growth factors from murine sarcoma virus-transformed cells. Proc. Natl. Acad. Sci. USA, 75, 4001–4005.

    Article  CAS  Google Scholar 

  7. Perroteau, I., Salomon, D., DeBortoli, M. et al (1986). Immunological detection and quantitation of alpha transforming growth factors in human breast carcinoma cells. Breast Cancer Res. Treat., 75, 201–210.

    Article  Google Scholar 

  8. Travers, M.T., Barrett-Lee, P.J., Berger, U. et al. (1988). Growth factor expression in normal, benign and malignant breast tissue. Br. Med. J., 296, 1621–1624.

    Article  CAS  Google Scholar 

  9. Barrett-Lee, P., Travers, M., Luqmani, Y., Coombes, R.C. (1990). Transcripts for transforming growth factors in breast cancer: clinical correlates. Br. J. Cancer, 61, 612–617.

    Article  PubMed  CAS  Google Scholar 

  10. Lippman, M.E., Dickson, R.B., Bates, S. et al. (1986). Autocrine and paracrine growth regulation of human breast cancer. Breast Cancer Res. Treat., 75, 59–70.

    Article  Google Scholar 

  11. MacDonald, R.G., Pfeffer, S.R., Coussens, L. et al. (1988). A single receptor binds both insulin-like growth factor II and mannose-6-phosphate. Science, 239, 1134–1137.

    Article  PubMed  CAS  Google Scholar 

  12. Pekonen, F., Partanen, S., Makinen, T., Rutanen, E-M. (1988). Receptors for epidermal growth factor and insulin-like growth factor I and their relationship to steroid receptors in human breast cancers. Cancer Res., 48, 1343–1347.

    PubMed  CAS  Google Scholar 

  13. Cullen, K.J., Yee, D., Paik, S. et al. (1988). Insulin-like growth factor II expression and activity in human breast cancer. Proc. Am. Assoc. Cancer Res., 29, 238 (Abstr. 947).

    Google Scholar 

  14. Heldin, C-H., Westermark, B., Wasteson, A. (1981). Specific receptor for platelet derived growth factor on cells derived from connective tissue and glia. Proc. Natl. Acad. Sci. USA, 78, 3664–3668.

    Article  PubMed  CAS  Google Scholar 

  15. Perez, R., Pascual, M., Macias, A., Lage, A. (1984). Epidermal growth factor receptors in human breast cancer. Breast Cancer Res. Treat., 4, 189–193.

    Article  PubMed  CAS  Google Scholar 

  16. Bates, S.E., Davidson, N.E., Valverius, E.M., et al. (1988). Expression of transforming growth factor α and its messenger ribonucleic acid in human breast cancer: its regulation by estrogen and its possible functional significance. Molec. Endocrinol., 2, 543–555.

    Article  CAS  Google Scholar 

  17. Knabbe, C., Lippman, M.E., Wakefield, L.M. et al. (1987). Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells. Cell, 48, 417–428.

    Article  PubMed  CAS  Google Scholar 

  18. Arteaga, C.L., Coronado, E., Osborne, C.K. (1988). Blockade of the epidermal growth factor receptor inhibits transforming growth factor α-induced but not estrogen-induced growth of hormone-dependent human breast cancer. Molec. Endocrinol., 2, 1064–1069.

    Article  CAS  Google Scholar 

  19. Slamon, D.J., Clark, G.M., Wong, S.G., Levin, W.J., Ullrich, A., McGuire, W.L. (1987). Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science,235, 177–182.

    Article  PubMed  CAS  Google Scholar 

  20. Varley, J.M., Swallow, J.E., Brammar, W.J., Whittaker, J.L., Walker, R.A. (1987). Alterations to either c-erbB-2(neu) or C-myc oncogenes in breast carcinomas correlate with poor short term prognosis. Oncogene, 1, 423–430.

    PubMed  CAS  Google Scholar 

  21. Ali, I.U, Campbell, G., Lidereau, R., Callahan, R. (1988). Lack of evidence for the prognostic significance of c-erbB-2 amplification in human breast cancers. Oncogene Res., 3, 139–146.

    PubMed  CAS  Google Scholar 

  22. Zhou, D.J., Ahuja, H., Cline, M.J. (1989). Proto-oncogene abnormalities in human breast cancer.: c-erbB-2 amplification does not correlate with recurrence of disease. Oncogene, 4, 105–108.

    PubMed  CAS  Google Scholar 

  23. Escot, C., Theillet, C., Lidereau, R., Spyratos, F., Champeme, M-H., Gest, J. and Callahan, R. (1986). Genetic alteration of the c-myc protooncogene (MYC) in human primary breast carcinomas. Proc. Natl. Acad. Sci,. USA, 83, 4834–4838.

    Article  PubMed  CAS  Google Scholar 

  24. Adnane, J., Gaudray, P., Simon, M.P., Simony-Lafontaine, J., Jeanteur, P., Theillet, C. (1989). Proto-oncogene amplification and human breast tumour phenotype. Oncogene, 4, 1389.

    PubMed  CAS  Google Scholar 

  25. Lidereau, R., Callahan, R., Dickson, C., Peters, G., Escot, C., Ali, I.U. (1988). Amplification of the int-2 gene in primary human breast tumours. Oncogene Res., 2, 285–291.

    PubMed  CAS  Google Scholar 

  26. Harris, A.L., Nicholson, S., Sainsbury, J.R.C. et al. (1989). Epidermal growth factor receptor: a marker of early relapse in breast cancer and tumor stage progression in bladder cancer: interactions with neu. In Furth, M., Greaves, M. (eds.), Cancer Cells, Vol. 7, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, 353–357.

    Google Scholar 

  27. Brown, G.L., Curtsinger, L., Brightwell, J.R. et al. (1986). Enhancement of epidermal regeneration by biosynthetic epidermal growth factor. J. Exp. Med., 163, 1319–1324.

    Article  PubMed  CAS  Google Scholar 

  28. Rosenberg, S.A., Lotze, M.T., Muul, A.E. et al. (1987). A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high dose interleukin-2 alone. N. Engl. J. Med., 316, 889–897.

    Article  PubMed  CAS  Google Scholar 

  29. Mendelsohn, J. (1989). Potential clinical applications of anti-EGF receptor monoclonal antibodies. In Furth, M., Greaves, M. (eds.), Cancer Cells, Vol.7, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, 343–345.

    Google Scholar 

  30. Stein, C.A., LaRocca, R.V., Thomas, R., McAtee, N., Myers, C.E. (1989). Suramin: an anticancer drug with a unique mechanism of action. J. Clin. Oncol., 7(4), 499–508.

    PubMed  CAS  Google Scholar 

  31. Bookstein, R., Shew, J-Y., Chen, P-L., Scully, P., Lee, W-H. (1990). Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene. Science, 247, 712–715.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Peter J. Barrett-Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Oncology Department St Thomas’ Hospital, and to Joint Breast Clinic, Royal Free Hospital, London, UK

    Basil A. Stoll FRCR, FFR (Honorary Consulting Physician) (Honorary Consulting Physician)

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Barrett-Lee, P.J. (1991). Growth Factor Expression in Breast Tissue. In: Stoll, B.A. (eds) Approaches to Breast Cancer Prevention. Developments in Oncology, vol 62. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-3742-3_4

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-3742-3_4

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-5664-9

  • Online ISBN: 978-94-011-3742-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation